IHS Chemical Week

EnviroTech :: Regulatory

Merck & Co. to Settle Vioxx Claims

11:03 AM MST | November 20, 2007 | Chemical Week Editorial Staff

Merck & Co. agreed earlier this month to pay a total of $4.85 billion to 47,000 groups of plaintiffs to settle a class-action lawsuit related to Vioxx, Merck’s former blockbuster painkiller drug that was withdrawn from the market in 2004. Vioxx was withdrawn because of side-effects including heart attacks and strokes that resulted in a number of patient deaths. Merck says it will pay the settlement into a fund and that plaintiffs may petition to receive a portion of the amount. Plaintiff groups include patients who had been prescribed Vioxx, and the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa